ACS BrightEdge

Executive Summary

ACS BrightEdge is the innovation, impact investment and venture capital arm of the American Cancer Society.

Focusing on early-stage companies developing cutting-edge, cancer-focused therapeutics, diagnostics, devices, and technologies.

Primarily early-stage investments.

Cancer-focused therapeutics, diagnostics, devices, and technologies.

Fund Size	N/A USD
Stages Focus	Early-Stage
Sectors Focus	HealthTech, Biotech, Oncology, Pharmacology, Philanthropy, Fundraising
Portfolio Size	2 companies

Active team contains 7 members (2 partners, 0 founders).

What is ACS BrightEdge?
ACS BrightEdge is the innovation, impact investment, and venture capital arm of the American Cancer Society, focusing on early-stage companies developing cancer-focused therapeutics, diagnostics, devices, and technologies.
Where is ACS BrightEdge located?
ACS BrightEdge is located in Kennesaw, United States.
When was ACS BrightEdge founded?
This information is not publicly available.
What type of investor is ACS BrightEdge?
ACS BrightEdge is a Corporate VC and VC Firm.
Does ACS BrightEdge invest in HealthTech?
Yes, ACS BrightEdge invests in HealthTech.
Does ACS BrightEdge invest in Biotech?
Yes, ACS BrightEdge invests in Biotech.
Does ACS BrightEdge invest in Oncology?
Yes, ACS BrightEdge invests in Oncology.
Does ACS BrightEdge invest in Pharmacology?
Yes, ACS BrightEdge invests in Pharmacology.
Does ACS BrightEdge invest in Philanthropy?
Yes, ACS BrightEdge invests in Philanthropy.
Does ACS BrightEdge invest in Fundraising?
Yes, ACS BrightEdge invests in Fundraising.